Company / Profit Margin
Amgen Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
21.0%
FY2025
5-year range
12.2% / 24.9%
FY2021-FY2025
Trend
+71.4%
vs FY2024
Sector context
#26 of 143
Health Care
What the data says
Amgen's profit margin of 21.0% is higher than 82% of companies in the Health Care sector (FY2025). Profit Margin returned to growth in FY2025 after 2 years of decline, reaching 21.0%.
Based on SEC 10-K filings.
21.0% in FY2025 with a 5-year CAGR of -7.6%. Top quartile in the Health Care sector.
Declined from 23.8% to 21.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -3.9pp
- 5-Year Change
- -7.6pp
- 10-Year Change
- -
Sector benchmark
Top 18% in Health CareTop 18% of 143This company 21.0% Sector average -899.4%
▼
+102.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 71.4% year-over-year.
- Currently 920.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2018.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.0% | +71.4% |
| FY2024 | 12.2% | -48.6% |
| FY2023 | 23.8% | -4.3% |
| FY2022 | 24.9% | +9.7% |
| FY2021 | 22.7% | -20.6% |
| FY2020 | 28.6% | -14.9% |
| FY2019 | 33.6% | -5.0% |
| FY2018 | 35.4% | +308.2% |
| FY2017 | 8.7% | -74.2% |
| FY2016 | 33.6% | +4.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026